Détermination de la puissance Relative d’un anticorps Monoclonal Anti-TNF (mAb) de neutralisants TNF en utilisant une méthode de Bioanalytical In Vitro

Overview

This protocol outlines a method for assessing the relative potency of anti-TNF-alpha monoclonal antibodies using WEHI 164 cells. It provides a comparative analysis of the neutralization efficiency of a reference mAb against a sample mAb.

Key Study Components

Area of Science

• Immunology
• Cell Biology
• Biotechnology

Background

• Anti-TNF-alpha monoclonal antibodies are used to neutralize the effects of TNF-alpha.
• WEHI 164 cells serve as a model for studying cytokine interactions.
• Understanding neutralization efficiency is crucial for therapeutic applications.
• Cells can be subjected to stress to evaluate their response to TNF-alpha.

Purpose of Study

• To measure the relative potency of different anti-TNF-alpha mAbs.
• To compare the neutralization efficiency of a reference mAb with a sample mAb.
• To provide a detailed protocol for researchers in the field.

Methods Used

• Cell culture of WEHI 164 cells.
• Application of anti-TNF-alpha mAbs to the cultured cells.
• Assessment of cell viability and apoptosis.
• Comparison of neutralization potency between mAbs.

Main Results

• Demonstrated differences in neutralization efficiency between mAbs.
• Provided quantitative data on the anti-apoptotic activity of tested mAbs.
• Established a reliable protocol for future studies.
• Highlighted the importance of receptor interactions in TNF-alpha signaling.

Conclusions

• The protocol is effective for comparing anti-TNF-alpha mAbs.
• Understanding neutralization mechanisms can inform therapeutic strategies.
• Further research is needed to explore additional mAb candidates.

Frequently Asked Questions